National Research Corp Stock
Your prediction
National Research Corp Stock
Pros and Cons of National Research Corp in the next few years
Pros
Cons
Performance of National Research Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| National Research Corp | 0.680% | - | - | - | - | - | - |
| Newtek Business Services Inc. | 1.690% | 4.850% | 17.525% | -23.952% | -18.720% | -43.398% | - |
| Mistras Group Inc. | - | 6.250% | -3.774% | 21.429% | 22.156% | 25.926% | 72.881% |
| ICF International Inc. | -2.670% | 4.167% | 11.940% | -36.441% | -33.628% | -23.077% | 21.951% |
News
NRC Health Announces Third Quarter 2025 Results
National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the third quarter 2025.
“We delivered our
NRC Health Announces Shane Harrison as Chief Financial Officer
National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare experience, is pleased to announce the appointment of Shane Harrison as its
NRC Health Announces Second Quarter 2025 Results
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2025.
CEO Statement
Trent S. Green, Chief Executive Officer of NRC Health


